Related Experiment Video
Updated: Jun 28, 2025

14:37
Modeling an Enzyme Active Site using Molecular Visualization Freeware
Published on: December 25, 2021
9.8K
Identifying Residues for Substrate Recognition in Human GPAT4 by Molecular Dynamics Simulations
Yulan Liu1,2, Yunong Xu1,2, Yinuo Xu1,2
1School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
International Journal of Molecular Sciences
|April 13, 2024
Summary
Researchers studied how glycerol-3-phosphate acyltransferase 4 (GPAT4) binds substrates using molecular dynamics. They found a flexible region and residue R427 are key to glycerol-3-phosphate recognition, aiding drug design.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Chemistry
Background:
- Glycerol-3-phosphate acyltransferase (GPAT) is crucial for triacylglycerol synthesis.
- Understanding GPAT substrate binding is vital for regulating cellular glycerol lipid production.
- GPAT4 is a key isoform involved in these pathways.
Purpose of the Study:
- To investigate the substrate recognition mechanism of human GPAT4.
- To elucidate how glycerol-3-phosphate (G3P) and palmitoyl-coenzyme A (CoA) bind to GPAT4.
- To provide insights for designing GPAT4 inhibitors.
Main Methods:
- Molecular dynamics (MD) simulations were employed to study GPAT4-substrate interactions.
- AlphaFold models were used to construct the GPAT4-substrate complex due to the lack of experimental structures.
- A validation study using GPAT1 demonstrated the reliability of the AlphaFold-based MD approach.
Main Results:
- MD simulations revealed that residue R427 plays a significant role in G3P recognition through a stable salt bridge.
- The flexibility of R427 allows G3P to interact with multiple binding sites on GPAT4.
- A unique flexible region in GPAT4, absent in GPAT1, contributes to this observed flexibility.
Conclusions:
- The study elucidates the substrate recognition mechanism of GPAT4.
- The findings highlight the importance of residue R427 and GPAT4's flexible regions in substrate binding.
- This research lays the groundwork for developing targeted GPAT4 inhibitors for therapeutic purposes.

